APOP | tickerfilter.com

Fundamental analysis

26%

Profitability 25%

Dept financing 7%

Liquidity 50%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-8.80%

1 Month

-28.77%

3 Months

-19.89%

6 Months

27.12%

1 Year

93.68%

2 Year

33.84%

Key data

Stock price

$11.64

P/E Ratio

0.00

DAY RANGE

$11.64 - $13.37

EPS

$0.00

52 WEEK RANGE

$6.64 - $35.52

52 WEEK CHANGE

$0.58

MARKET CAP

11.377 M

YIELD

N/A

SHARES OUTSTANDING

977.373 K

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.25

PUBLIC FLOAT

AVERAGE 10 VOLUME

$56,869

AVERAGE 30 VOLUME

$130,504

Company detail

CEO: Shai Yarkoni
Region: US
Website: cellect.co
Employees: 2,020
IPO year: -

Issue type: American Depository Receipt (ADR’s)
Market: NASDAQ
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Cellect Biotechnology has developed a breakthrough technology, for the selection of stem cells from any given tissue, that aims to improve a variety of stem cell-based therapies.

APOP - Cellect Biotechnology Ltd. - ADR